Omnicell (OMCL)
(Delayed Data from NSDQ)
$44.62 USD
+1.20 (2.76%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $44.44 -0.18 (-0.40%) 6:26 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Omnicell, Inc. [OMCL]
Reports for Purchase
Showing records 121 - 140 ( 337 total )
Company: Omnicell, Inc.
Industry: Medical Info Systems
Miss + Substantial Guide Down:Valuation Implies Troughing Setup (ex. Great Recession);Remain OW
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Software Expansion Intact; Attractive Entry Point for High-Quality Growth Story
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Reiterated 2025 Revenue Targets, but Margin Targets Lowered ~100 bps
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Omnicell, Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department